AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)

计划入组 30 人 · 首次发布于 2026 年 6 月 11 日

A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

计划入组 27 人 · 首次发布于 2022 年 11 月 7 日

A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

计划入组 2 人 · 首次发布于 2025 年 6 月 26 日

Hib conjugate vaccine (Bharat Biotech)

Typhoid vaccine Vi polysaccharide (Bharat Biotech)

HPV vaccine, Bharat Biotech

BHARAT BIOTECH INTERNATIONAL LIMITED

India

Bharat Biotech International Ltd.

India

BHARAT SERUMS AND VACCINES LIMITED

India

India to Launch Aarogya Setu 2.0 and National Drug Registry in Major Digital Health Push

India's Nafithromycin Offers New Hope Against Drug-Resistant Pneumonia

Amway India Launches Phase II of Power of 5 School Nutrition Programme in New Delhi, Targeting 15,000 Beneficiaries